Canada markets closed

Love Pharma Inc. (LUV.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.01000.0000 (0.00%)
At close: 03:58PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 3.15M
Enterprise Value 3.16M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.70
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.32

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-66.67%
S&P500 52-Week Change 3-8.83%
52 Week High 30.1500
52 Week Low 30.0100
50-Day Moving Average 30.0127
200-Day Moving Average 30.0310

Share Statistics

Avg Vol (3 month) 3155.29k
Avg Vol (10 day) 3229.68k
Shares Outstanding 5314.92M
Implied Shares Outstanding 6N/A
Float 8322.72M
% Held by Insiders 12.08%
% Held by Institutions 10.00%
Shares Short (May 12, 2022) 494
Short Ratio (May 12, 2022) 40
Short % of Float (May 12, 2022) 4N/A
Short % of Shares Outstanding (May 12, 2022) 40.00%
Shares Short (prior month Apr 13, 2022) 4162.82k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Jan 21, 2018
Last Split Factor 21:2
Last Split Date 3Sept 29, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-9.61M
Diluted EPS (ttm)-0.0340
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)524.4k
Total Cash Per Share (mrq)0
Total Debt (mrq)226.25k
Total Debt/Equity (mrq)19.39
Current Ratio (mrq)0.99
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-1.3M
Levered Free Cash Flow (ttm)N/A